Olivia Lenhart has remained on a ventilator since last month, when she was taken to the hospital with low oxygen levels and ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...